A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Recruiting · NCT05417932 · Registry updated 2025-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma | Hepatitis B Virus Related Hepatocellular Carcinoma; Hepatocellular Carcinoma Recurrent | Recruiting | Phase 1 / Phase 2 | 2025-02-18 | NCT05417932 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| SCG Cell Therapy Pte. Ltd. | 2 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hong Kong is. | Hong Kong | Hong Kong | 1 |
| Hong Kong NT | Hong Kong | Hong Kong | 1 |
| New York | New York | United States | 1 |
| New York | New York | United States | 2 |
| Singapore | Singapore | Singapore | 1 |
| Singapore | Singapore | Singapore | 1 |